Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine or Prednisone for Recurrent In-stent Restenosis
NCT06090890Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Oct 2023
- Primary completion
- Oct 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine, prednisone in in-stent restenosis (ISR), sponsored by Fuwai Hospital. Started Oct 2023; status: recruiting.
02
Drugs
colchicineprednisone
03
Conditions
in-stent restenosis (ISR)
Beyond the preview
Go deeper on NCT06090890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06090890.